Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry.
Samar Samy Abd ElHafeezAnneke KramerMustafa AriciMiha ArnolAnders ÅsbergSamira BellJulie BelliereCarmen Díaz CorteGema Fernández FresnedoMarc HemmelderLine HeylenKristine HommelJulia KerschbaumRadomir NaumovićDorothea NitschRafael SantamariaPatrik FinneRunolfur PalssonMaria PippiasHalima ResicMai RosenbergCarmen Santiuste de PablosMårten M SegelmarkSøren Schwartz SørensenMaria Jose SolerEnrico VidalKitty J JagerAlberto Ortiz ArduanVianda S StelPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
The incidence of KRT for ESKD due to PGD showed large differences between countries and was highest and increasing for IgAN and FSGS. Lack of kidney biopsy facilities in some countries may have affected accurate assignment of the cause of ESKD. The recognition of the incidence and outcomes of KRT among different PGD subgroups may contribute to a more individualized patient care approach.